Following a string of FDA resignations, Patrizia Cavazzoni has announced that her last day will be 18 January.
In an interview, outgoing FDA commissioner Robert Califf was wary of the Trump administration but unapologetic about ...
The FDA granted Aduhelm an accelerated approval, meaning that Biogen has to carry out a post-marketing trial to confirm that it is effective, but critics say results from that will be years away.
The Food and Drug Administration (FDA) has reaffirmed that Mounjaro and Zepbound are no longer in shortage following a reevaluation of its decision to remove it from the federal drug shortage list ...
The US Food and Drugs Administration (FDA) has confirmed that its director of the Centre for Drug Evaluation and Research (CDER), Patrizia Cavazzoni, has announced her resignation ahead of Donald ...